The cumulative survival rate of 48% indicates that there may be significant clinical benefits for COVID-19 patients who receive PP in conjunction with ECMO.
← all excerpts
Prone Positioning During Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome With COVID-19: A Meta-Analysis.
1
—
—